BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 31296736)

  • 21. IL-23-mediated mononuclear phagocyte crosstalk protects mice from Citrobacter rodentium-induced colon immunopathology.
    Aychek T; Mildner A; Yona S; Kim KW; Lampl N; Reich-Zeliger S; Boon L; Yogev N; Waisman A; Cua DJ; Jung S
    Nat Commun; 2015 Mar; 6():6525. PubMed ID: 25761673
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Group 3 innate lymphoid cells accumulate and exhibit disease-induced activation in the meninges in EAE.
    Hatfield JK; Brown MA
    Cell Immunol; 2015 Oct; 297(2):69-79. PubMed ID: 26163773
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Constitutive induction of intestinal Tc17 cells in the absence of hematopoietic cell-specific MHC class II expression.
    Rubino SJ; Geddes K; Magalhaes JG; Streutker C; Philpott DJ; Girardin SE
    Eur J Immunol; 2013 Nov; 43(11):2896-906. PubMed ID: 23881368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The chemokine receptor CXCR6 controls the functional topography of interleukin-22 producing intestinal innate lymphoid cells.
    Satoh-Takayama N; Serafini N; Verrier T; Rekiki A; Renauld JC; Frankel G; Di Santo JP
    Immunity; 2014 Nov; 41(5):776-88. PubMed ID: 25456160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Th17 cell development: from the cradle to the grave.
    Zúñiga LA; Jain R; Haines C; Cua DJ
    Immunol Rev; 2013 Mar; 252(1):78-88. PubMed ID: 23405896
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Tumor Necrosis Factor Superfamily Member RANKL Suppresses Effector Cytokine Production in Group 3 Innate Lymphoid Cells.
    Bando JK; Gilfillan S; Song C; McDonald KG; Huang SC; Newberry RD; Kobayashi Y; Allan DSJ; Carlyle JR; Cella M; Colonna M
    Immunity; 2018 Jun; 48(6):1208-1219.e4. PubMed ID: 29858011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigenetic activation during T helper 17 cell differentiation is mediated by Tripartite motif containing 28.
    Jiang Y; Liu Y; Lu H; Sun SC; Jin W; Wang X; Dong C
    Nat Commun; 2018 Apr; 9(1):1424. PubMed ID: 29651155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcription factor Tox2 is required for metabolic adaptation and tissue residency of ILC3 in the gut.
    Das A; Martinez-Ruiz GU; Bouladoux N; Stacy A; Moraly J; Vega-Sendino M; Zhao Y; Lavaert M; Ding Y; Morales-Sanchez A; Harly C; Seedhom MO; Chari R; Awasthi P; Ikeuchi T; Wang Y; Zhu J; Moutsopoulos NM; Chen W; Yewdell JW; Shapiro VS; Ruiz S; Taylor N; Belkaid Y; Bhandoola A
    Immunity; 2024 May; 57(5):1019-1036.e9. PubMed ID: 38677292
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PPARα suppresses Th17 cell differentiation through IL-6/STAT3/RORγt pathway in experimental autoimmune myocarditis.
    Chang H; Zhao F; Xie X; Liao Y; Song Y; Liu C; Wu Y; Wang Y; Liu D; Wang Y; Zou J; Qi Z
    Exp Cell Res; 2019 Feb; 375(1):22-30. PubMed ID: 30557558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unique and redundant functions of NKp46+ ILC3s in models of intestinal inflammation.
    Song C; Lee JS; Gilfillan S; Robinette ML; Newberry RD; Stappenbeck TS; Mack M; Cella M; Colonna M
    J Exp Med; 2015 Oct; 212(11):1869-82. PubMed ID: 26458769
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IκBNS regulates murine Th17 differentiation during gut inflammation and infection.
    Annemann M; Wang Z; Plaza-Sirvent C; Glauben R; Schuster M; Ewald Sander F; Mamareli P; Kühl AA; Siegmund B; Lochner M; Schmitz I
    J Immunol; 2015 Mar; 194(6):2888-98. PubMed ID: 25694610
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense.
    Satoh-Takayama N; Vosshenrich CA; Lesjean-Pottier S; Sawa S; Lochner M; Rattis F; Mention JJ; Thiam K; Cerf-Bensussan N; Mandelboim O; Eberl G; Di Santo JP
    Immunity; 2008 Dec; 29(6):958-70. PubMed ID: 19084435
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapamycin attenuates acute lung injury induced by LPS through inhibition of Th17 cell proliferation in mice.
    Yan Z; Xiaoyu Z; Zhixin S; Di Q; Xinyu D; Jing X; Jing H; Wang D; Xi Z; Chunrong Z; Daoxin W
    Sci Rep; 2016 Feb; 6():20156. PubMed ID: 26888095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dysregulated development of IL-17- and IL-21-expressing follicular helper T cells and increased germinal center formation in the absence of RORγt.
    Wichner K; Stauss D; Kampfrath B; Krüger K; Müller G; Rehm A; Lipp M; Höpken UE
    FASEB J; 2016 Feb; 30(2):761-74. PubMed ID: 26499265
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lymphotoxin-β receptor-independent development of intestinal IL-22-producing NKp46+ innate lymphoid cells.
    Satoh-Takayama N; Lesjean-Pottier S; Sawa S; Vosshenrich CA; Eberl G; Di Santo JP
    Eur J Immunol; 2011 Mar; 41(3):780-6. PubMed ID: 21341264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological inhibition of RORγt suppresses the Th17 pathway and alleviates arthritis in vivo.
    Guendisch U; Weiss J; Ecoeur F; Riker JC; Kaupmann K; Kallen J; Hintermann S; Orain D; Dawson J; Billich A; Guntermann C
    PLoS One; 2017; 12(11):e0188391. PubMed ID: 29155882
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Runx3 specifies lineage commitment of innate lymphoid cells.
    Ebihara T; Song C; Ryu SH; Plougastel-Douglas B; Yang L; Levanon D; Groner Y; Bern MD; Stappenbeck TS; Colonna M; Egawa T; Yokoyama WM
    Nat Immunol; 2015 Nov; 16(11):1124-33. PubMed ID: 26414766
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dichotomous regulation of group 3 innate lymphoid cells by nongastric
    Bostick JW; Wang Y; Shen Z; Ge Y; Brown J; Chen ZE; Mohamadzadeh M; Fox JG; Zhou L
    Proc Natl Acad Sci U S A; 2019 Dec; 116(49):24760-24769. PubMed ID: 31740609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interleukin-17B Antagonizes Interleukin-25-Mediated Mucosal Inflammation.
    Reynolds JM; Lee YH; Shi Y; Wang X; Angkasekwinai P; Nallaparaju KC; Flaherty S; Chang SH; Watarai H; Dong C
    Immunity; 2015 Apr; 42(4):692-703. PubMed ID: 25888259
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conversion of Th17 into IL-17A(neg) regulatory T cells: a novel mechanism in prolonged allograft survival promoted by mesenchymal stem cell-supported minimized immunosuppressive therapy.
    Obermajer N; Popp FC; Soeder Y; Haarer J; Geissler EK; Schlitt HJ; Dahlke MH
    J Immunol; 2014 Nov; 193(10):4988-99. PubMed ID: 25305313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.